|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 322.20 SEK | +0.69% |
|
+5.02% | +3.67% |
| 09/02 | Priority Review in China for Subcutaneous Leqembi Treatment | FW |
| 06/02 | Bioarctic reports Q4 sales of Leqembi at yen 20.7 billion | RE |
a5716aa46c929ba812be0fdf0f3.2p4xAQIvQ82k7EX7c7i9dDTYTOWDPk3P1AYaFAxEpbE.u-RobnNIIJKQnnTOKo75EgG_P5_hVAqLmldvfkB86MSSqQlkMGoU_tWEDA~3ff3cf9e2dc977ecc42d2c50efd402a8
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















